GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Net Interest Income

Bioceltix (WAR:BCX) Net Interest Income : zł0.11 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bioceltix Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Bioceltix's net interest income for the three months ended in Sep. 2024 was zł0.06 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was zł0.11 Mil.

Bioceltix Net Interest Income Historical Data

The historical data trend for Bioceltix's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioceltix Net Interest Income Chart

Bioceltix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
-0.02 0.01 -0.02 -0.07 0.25

Bioceltix Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.06 0.02 -0.02 0.06

Bioceltix Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioceltix Net Interest Income Related Terms

Thank you for viewing the detailed overview of Bioceltix's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioceltix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Net Interest Income
Comparable Companies
WAR:RVU WAR:BIO WAR:SVE WAR:MAB WAR:MOC WAR:PTG WAR:CTX WAR:URT WAR:NNG WAR:RDG VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
XI3:Germany
Address
Bierutowska 57-59 Street, Wroclaw, POL, 51-317
Website
https://www.bioceltix.com
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.